Uganda’s National Drug Authority has just approved Lenacapavir, a twice-yearly dose PrEP manufactured by Gilead, a USA based company
- Advertisement -
- Advertisement -
Trending Now
We deliver timely factual national and regional news, bringing Uganda’s stories to the forefront while connecting audiences to developments across Africa and worldwide.